The big shakeup in the inner executive circle around CEO Emma Walmsley is continuing today, with two top appointments at GlaxoSmithKline — and one key exit.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,